Escherichia coli

未知生产厂商

Escherichia coli is a probiotic indicated to treat urinary tract infections and irritable bowel syndrome.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Escherichia coli is a probiotic indicated to treat urinary tract infections and irritable bowel syndrome.

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Enterohemorragic escherichia coli vaccine
EP 2295075 A1申请人: UNIV SASKATCHEWAN优先权: 2002
EP
US
7 件公开
Vaccines against Escherichia coli O157 infection
US 7553490 B2申请人: US HEALTH优先权: 2001
US
7 件公开
ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF
- US 2021268095 A1
  申请人: PFIZER优先权: 2020
  CN
  US
  WO
  6 件公开
- US 11260119 B2
  申请人: PFIZER优先权: 2019
  US
  3 件公开
- US 2023000966 A1
  申请人: PFIZER优先权: 2019
  CN
  US
  2 件公开
- EP 4237428 A2
  申请人: PFIZER优先权: 2020
  EP
  WO
  2 件公开
- US 12138302 B2
  申请人: PFIZER优先权: 2021
  US
  2 件公开
- CN 116615439 A
  申请人: PFIZER优先权: 2021
  CN
Pathogenic Escherichia coli associated protein espA
US 7078193 B2申请人: UNIV BRITISH COLUMBIA优先权: 2001
US
6 件公开
Immunogens from uropathogenic escherichia coli
- EP 2298795 A1
  申请人: NOVARTIS VACCINES & DIAGNOSTIC优先权: 2005
  CN
  EP
  US
  5 件公开
- US 2010166788 A1
  申请人: NOVARTIS VACCINES & DIAGNOSTIC优先权: 2007
  US
  2 件公开
Adhesin as immunogen against Escherichia coli
EP 2471549 A1申请人: US NAVY优先权: 2006
EP
US
5 件公开
Detoxified Escherichia coli immunogens
US 8871214 B2申请人: SERINO LAURA优先权: 2010
CN
US
5 件公开
ESCHERICHIA COLI VACCINE COMBINATION
US 2015118261 A1申请人: SERINO LAURA优先权: 2011
CN
US
4 件公开
Escherichia coli immunogens with improved solubility
US 8470341 B2申请人: SERINO LAURA优先权: 2009
US
4 件公开
Immunogenic Escherichia coli heat stable enterotoxin
US 8728478 B2申请人: SAEED A MAHDI优先权: 2009
US
4 件公开

药物

Escherichia coli

概览

相关疾病

专利

ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF

Immunogens from uropathogenic escherichia coli